CALL - SPRINTER OPEN END - FRESENIUS Share Price

Certificat

DE000VV643P4

Delayed Deutsche Boerse AG 12:40:27 22/05/2024 BST
7.75 EUR +1.57% Intraday chart for CALL - SPRINTER OPEN END - FRESENIUS
Current month-5.80%
1 month+6.42%
Date Price Change
22/05/24 7.75 +1.57%
21/05/24 7.63 -5.22%
20/05/24 8.05 -2.31%
17/05/24 8.24 -5.50%
16/05/24 8.72 -1.36%

Delayed Quote Deutsche Boerse AG

Last update May 22, 2024 at 12:40 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Vontobel Vontobel
WKN VV643P
ISINDE000VV643P4
Date issued 23/09/2022
Strike 19.92
Maturity Unlimited
Parity 1 : 1
Emission price 3.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.27
Lowest since issue 1.41
Spread 0.03
Spread %0.39%

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
27.52 EUR
Average target price
36.72 EUR
Spread / Average Target
+33.45%
Consensus